The Chemical Differences Between EPA and DHA

Lipid Effects of Drug Classes in Dyslipidemia and Hypertriglyceridemia

Icosapent Ethyl (Pure EPA) Median Placebo-Adjusted Change From Baseline for Efficacy End Points

Select Omega-3 Outcomes Studies

Anti Inflammatory Effects of Omega-3 Fatty Acids

Prescription-only Omega-3s vs Dietary Supplement Omega-3s

Mechanisms by Which EPA May Lower CVD

Incidence of Cancer Diagnosis With Omega-3 Fatty Acids

Effects of Omega-3 on Incident Heart Failure GISSI-Heart Failure Study

Omega-3 Ethyl Esters and Lipid Levels in Patients With Triglycerides > 500 mg/dL

Use of Omega 3 Fatty Acids In Clinical Practice

Safety of Omega-3 Fatty Acids

Reduction of Cardiovascular Events With EPA – Intervention Trial

Abbreviations

Abbreviations (cont)

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)